Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study

  1. Arrabal Polo, M.Á.
  2. Melgarejo Segura, M.T.
  3. Yáñez Castillo, Y.
  4. Morales Martínez, A.
  5. Pareja Vílchez, M.
  6. Arrabal Martín, M.
Journal:
Journal of Cancer Research and Clinical Oncology

ISSN: 1432-1335,  0171-5216

Year of publication: 2023

Volume: 149

Issue: 10

Pages: 7453-7459

Type: Article

DOI: 10.1007/S00432-023-04688-0 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus